Aminoquinoline derivatives and uses thereof
US9567316B2 · kind B2 · utility
0Cited by
1References
6Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 28, 2013 |
| Grant date | Feb 14, 2017 |
| Priority date | — |
| Expiry date | Feb 28, 2033 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are aminoquinoline and aminoacridine based hybrids, pharmaceutical compositions and medicaments that include such aminoquinoline and aminoacridine based hybrids, and methods of using such compounds for diagnosing and/or treating infections, neurodegerative diseases or disorders, inflammation, inflammation associated diseases and disorders, and/or diseases or disorders that are treatable with dopamine agonists such as the restless leg syndrome.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.